Company intelligence / Profile preview

Buysydr

Ownership: Private
Development stage: Other

Overview

Buysydr appears to be an investment firm or hedge-fund-style entity rather than a life science, biotech, pharma, or healthcare operating company. Public web references to Buysydr are sparse and mainly occur in professional biographies describing prior employment in life science investing roles. I could not find evidence that Buysydr develops therapeutics, operates a drug pipeline, or provides healthcare products or services. Based on the available evidence, it should not be classified as a biotech or healthcare company.

Industry: Investors

Beyond the preview

Go deeper on Buysydr.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Buysydr.

Explore the full profile